Figure 6. Serum CA15-3 kinetics.
1st line, palbociclib plus letrozole; 2nd line, fulvestrant; 3rd line, tegafur; RT, radiotherapy with the hydrogen peroxide bolus; CA15-3, cancer antigen 15-3.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.